Characterizing the Tumor Immune Microenvironment with Tyramide-Based Multiplex Immunofluorescence

Area of Science:

• Oncology
• Immunology
• Biotechnology

Background:

• Multiplex immunofluorescence (mIF) is vital for immune profiling the tumor microenvironment.
• Understanding cancer-immune interplay and identifying immunotherapy biomarkers are key research areas.
• Standardization of mIF protocols is needed for clinical translation.

Purpose of the Study:

• To develop and validate automated mIF protocols for enhanced reproducibility and throughput.
• To characterize the tumor immune microenvironment using two distinct mIF panels.
• To facilitate the transition of mIF techniques into clinical diagnostic applications.

Main Methods:

• Utilized an automated slide stainer with tyramide signal amplification (TSA) for mIF.
• Developed two mIF panels targeting immune cells (CD3, CD20, CD117, FOXP3, Ki67, CD8, PD-1, PD-L1, CD68) and tumor markers (pancytokeratins).
• Employed multispectral imaging (Vectra 3.0) and outlined various image analysis methods for cell identification and spatial association.

Main Results:

• Demonstrated the successful application of automated mIF for high-throughput immune profiling.
• Established two comprehensive mIF panels for detailed characterization of the tumor immune microenvironment.
• Provided a framework for image analysis to quantify cellular phenotypes and interactions.

Conclusions:

• Automated mIF protocols significantly improve reproducibility and efficiency compared to manual methods.
• These standardized mIF protocols are valuable tools for immune profiling and biomarker discovery in cancer research.
• The developed methods support the advancement of mIF for clinical diagnostics and immunotherapy response prediction.